Boehringer Ingelheim: External Collaborative Research (ECR)

    Boehringer Ingelheim Pharmaceuticals, Inc. (BIPI) is dedicated to supporting innovative projects and programs that enhance the knowledge and understanding of diseases and technological advancements. Their commitment is toward advancing scientific awareness and technologies for public health and welfare in various therapeutic areas of interest. They aim to further scientific progress while ensuring that the projects they support maintain independent control over their goals and dissemination of knowledge.

    Type of Support

    Overview

    The External Collaborative Research (ECR) program by Boehringer Ingelheim is designed to support collaboration on studies in distinct therapeutic areas by offering drug and/or financial backing. Key areas of interest include Cardio-Renal-Metabolic systems, with a focus on the effects and utilization of empagliflozin, real-world implementation of guideline-based management, treatment pathways, provider impact, and transition-of-care models. In Mental Health, the program targets the evaluation of patient assessment and treatment landscapes in conditions such as Schizophrenia, PTSD, and Major Depressive Disorder, along with the role of digital therapeutics. Dermatology research is encouraged on the natural course, comorbidities, patient-reported outcomes, therapy limitations, pathogenesis, and management of Generalized Pustular Psoriasis (GPP). Oncology-focused research is sought on Soft Tissue Sarcoma, Biliary Tract Cancer, and Non-Small Cell Lung Cancer, with an emphasis on real-world data and novel treatment combinations. For Respiratory conditions, studies on Asthma and COPD are encouraged, focusing on pharmacological management, healthcare resource utilization, and effectiveness of specific treatments, alongside research on Fibrosing Interstitial Lung Diseases (ILD) about diagnostic tools, disease management, and non-pharmacologic care.

    Eligibility

    Organization's Location
    labore minim
    Program Location
    officia
    Organization Type
    Tempor
    Commodo in
    Cillum
    Exercitation Lorem ad veniam
    Do laborum cillum
    Consequat adipisicing esse ullamco
    Other
    • esse sunt do cillum incididunt

    Ineligibility

    Ullamco consequat aliqua consectetur consequat tempor consectetur ullamco occaecat dolore
    Officia labore duis ullamco velit amet ipsum mollit ut et est

    Submission

    Visit Apply for more information.
    2 of 2 free pages viewed this month
    Sign up to view this and 12k+ more grant opportunities
    or
    Already have an account?Log in